SCHEMBL23850307

SCHEMBL23850307

Cc1c(Br)c(COC(=O)NC(C)C)nn1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 3/20 0.34
TOP2A P11388 2/20 0.34
TOP2B Q02880 2/20 0.34
LMNA P02545 1/20 0.33
HTT P42858 4/20 0.33
KDM4E B2RXH2 3/20 0.33
APAF1 O14727 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ALPL P05186 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
GALR3 O60755 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21835474 0.84 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL23850118 0.84 TOP2A (0.33) RAB9ASMN1; SMN2NPC1TOP2ATOP2B
SCHEMBL23850108 0.75 ALDH1A1 (0.38) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL30450496 0.73 KMT2A (0.37) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL21835562 0.68 SMN1; SMN2 (0.36) SMN1; SMN2HTTKDM4EGALR3CYP1A2
SCHEMBL13799634 0.67 HTT (0.40) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL4163341 0.66 CSNK2A1 (0.35) RAB9ASMN1; SMN2NPC1MEN1KMT2A
SCHEMBL9276114 0.66 TOP2A (0.36) RAB9ASMN1; SMN2NPC1TOP2ATOP2B
SCHEMBL21835477 0.66 SMN1; SMN2 (0.35) SMN1; SMN2KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL23850305 0.66 HTT (0.37) RAB9ASMN1; SMN2NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883573-A1 MACROCYCLIC INHIBITORS OF DYRK1A Dana-Farber Cancer Institute, Inc. (US) 2021-09-29 EP disclosed